ESP Pharma
AcquiredEdison, United States · Founded 2002
- Headquarters
- Edison, New Jersey
- Employees
- 51–200
- Founded
- 2002
- Business Model
- B2B
- Acquisition Date
- Mar 2005
Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.
About
ESP Pharma was founded in April 2002 and began operations in May 2002 with the acquisition of four in-market therapeutics from Wyeth. Its 'Buy and Build, Search and Develop' business plan focused on selectively acquiring approved and late-stage development products addressing the needs of the acute-care hospital market. Its products included Cardene IV (nicardipine hydrochloride injection) for the short-term treatment of hypertension, and in September 2002 it established its own hospital sales force of experienced pharmaceutical representatives.
Summary
ESP Pharma is a Healthcare company based in Edison, United States, founded in 2002. Investors include Protein Design Labs (PDL BioPharma).
Exit History
Mar 2005
Investors
Similar Companies
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
China's leading blood products manufacturer
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/esp-pharma"><img src="https://indexed.vc/api/badge/company/esp-pharma" alt="ESP Pharma on Indexed.vc" width="260" height="76" /></a>